Amedeo's Top 20

Amedeo Smart

Independent Medical Education

06 April 2015

Multidisciplinary Journal Club

  1. Klein SL, Pekosz A.
    Sex-based Biology and the Rational Design of Influenza Vaccination Strategies.
    J Infect Dis 2014;209 :S114-9.

  1. Dawson R, Diacon AH, Everitt D, van Niekerk C, et al.
    Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible
    Lancet 2015.

  2. Rolfes M, Blanton L, Brammer L, Smith S, et al.
    Update: Influenza Activity - United States, September 28-December 6, 2014.
    MMWR Morb Mortal Wkly Rep 2014;63:1189-1194.

  3. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, et al.
    Early estimates of seasonal influenza vaccine effectiveness - United States, january 2015.
    MMWR Morb Mortal Wkly Rep 2015;64:10-5.

  4. Liira J, Verbeek J, Ruotsalainen J.
    Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.
    JAMA 2015;313:961-2.

  1. Nienaber CA, Clough RE.
    Management of acute aortic dissection.
    Lancet 2015;385:800-11.

  2. Dybkaer K, Bogsted M, Falgreen S, Bodker JS, et al.
    Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis.
    J Clin Oncol 2015.

  3. Joseph U, Linster M, Suzuki Y, Krauss S, et al.
    Adaptation of Pandemic H2N2 Influenza A Viruses in Humans.
    J Virol 2014.

  4. Pascual E, Mata CP, Gomez-Blanco J, Moreno N, et al.
    Structural basis for development of avian virus capsids to display influenza virus proteins for induction of protective immunity.
    J Virol 2014.

  5. Cooper DA, Banerjee S, Chakrabarti A, Garcia-Sastre A, et al.
    Ribonuclease L Targets Distinct Sites in Influenza A Virus RNAs.
    J Virol 2014.

  1. Cox A, Baker SF, Nogales A, Martinez-Sobrido L, et al.
    Development of a mouse-adapted, live-attenuated influenza virus that permits in vivo analysis of enhancements to the safety of LAIV.
    J Virol 2014.

  2. Gil A, Yassai MB, Naumov YN, Selin LK, et al.
    Narrowing of human influenza A virus specific T cell receptor alpha and beta repertoire with increasing age.
    J Virol 2015.

  3. Komori M, Blake A, Greenwood M, Lin YC, et al.
    CSF markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Ann Neurol 2015.

  4. Cattoli G , Milani A, Temperton N, Zecchin B, et al.
    ANTIGENIC DRIFT IN H5N1 AVIAN INFLUENZA IN POULTRY IS DRIVEN BY MUTATIONS IN MAJOR ANTIGENIC SITES OF THE HEMAGGLUTININ MOLECULE ANALOGOUS TO HUMAN INFLUENZA.
    J Virol 2011.

  5. Kappos L, O'Connor P, Radue EW, Polman C, et al.
    Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
    Neurology 2015.

  1. Gorse GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, et al.
    Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Vaccine 2015.

  2. Curran E, Stock W.
    How I Treat: Acute Lymphoblastic Leukemia in Older Adolescents and Young Adults (AYAs).
    Blood 2015.

  3. Kim M , Yim JH, Kim SY, Kim HS, et al.
    In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.
    Antiviral Res 2011.

  4. Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, et al.
    Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    JAMA 2015;313:1240-8.

  5. Smith TG , Ellison JA, Ma X, Kuzmina N, et al.
    An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
    Vaccine 2013.


more..

Privacy Policy